Source: iQoncept / Shutterstock
Janux Therapeutics (NASDAQ:JANX) just reported results for the first quarter of 2024.
- Janux Therapeutics reported earnings per share of -30 cents. This was above the analyst estimate for EPS of -33 cents.
- The company reported revenue of $1.25 million.
- This was 64.74% better than the analyst estimate for revenue of $760,000.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/janx-stock-earnings-janux-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC